Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2012 Q2- Text added to 2012 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
acknowledged, ADHD, AGILE, analyzed, analyzing, AstraZeneca, attention, Austria, Auxilium, Baceloneta, Belgium, bioavailability, Bosulif, capsule, chamber, Chinese, CII, CNS, confirmatory, Cosmetic, Denmark, dual, endorsed, Eurasian, exact, examination, extraction, feed, Food, fungal, guilty, Hisun, HPP, inspection, Lambert, Luxembourg, main, mental, methylphenidate, Mexican, mg, misbranding, misdemeanor, modified, mortality, mutual, Neisseria, Nexium, NextWave, offense, opportunity, OTC, pack, packaging, path, penalty, peso, Peyronie, plc, plead, PREA, prophylactic, Quillivant, RAR, RCC, registered, rescinded, revert, serogroup, sorafenib, statistical, statistically, suspension, Sweden, syringe, theDOJ, twelve, Warner, warranted, winning, wrongdoing, Xiapex, Zhejiang
Valuein 2012 Q2 filing- Value in 2012 Q3 filing
Original filings
Filing view